Noncoding RNAs active in dopamine neurons are a surprising link between genetic risk and Parkinson’s disease.
About Academic Web Pages
This author has yet to write their bio.
Meanwhile lets just say that we are proud Academic Web Pages contributed a whooping 39 entries.
This risk assessment tool estimates the chance of a person with Parkinson’s disease to develop global cognitive impairment. More information may be found at Cognitive Risk Score Calculator for Parkinson’s Disease
BRAINcode is an encyclopedia of the entire RNA content of dopamine and pyramidal neurons in the human brain.
More information may be found at BRAINcode Project
Dr. Dina Katabi visits the Advanced Center for Parkinson’s Disease Research to present on new innovations in mobile and wireless technology with application to digital health.
Award-winning actor Alan Alda is doing a lot of the right things to treat Parkinson’s disease, a Harvard researcher said on the day the M.A.S.H. star broke the news of his troubling diagnosis.
Learn more about the Parkinson’s disease study specifically targeting the GBA gene!
Dr. Jie Shen and her team describe an essential role of LRRK in the brain during aging that may help shed light on the causes of PD.
Team makes a surprising discovery that some asthma medicines may also hold the potential to treat or help prevent Parkinson’s disease.
A new tool from researchers at Harvard Medical School may allow investigators to predict cognitive decline in people with Parkinson’s disease (PD), which could help design clinical trials and test new therapies. The tool uses an algorithm combining varied personal details — age at onset, baseline score on the Mini Mental State Examination, years of education, motor exam score, sex, depression, and GBA mutation status.